Drug firm Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for Bimatoprost Ophthalmic Solution, used to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.
For more information on commodity tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
Sign up here with your email